Biohaven Ltd [NYSE: BHVN] jumped around 5.55 points on Monday, while shares priced at $45.94 at the close of the session, up 13.74%.
Compared to the average trading volume of 939.82K shares, BHVN reached a trading volume of 6248730 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Biohaven Ltd [BHVN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BHVN shares is $60.36 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BHVN stock is a recommendation set at 1.15. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Jefferies have made an estimate for Biohaven Ltd shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 16, 2024. While these analysts kept the previous recommendation, Bernstein raised their target price to Outperform. The new note on the price target was released on September 04, 2024, representing the official price target for Biohaven Ltd stock. Previously, the target price had yet another raise to $58, while Morgan Stanley analysts kept a Overweight rating on BHVN stock.
The Average True Range (ATR) for Biohaven Ltd is set at 2.34 The Price to Book ratio for the last quarter was 11.06, with the Price to Cash per share for the same quarter was set at 4.62.
How has BHVN stock performed recently?
Biohaven Ltd [BHVN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 17.73. With this latest performance, BHVN shares gained by 14.96% in over the last four-week period, additionally sinking by -17.74% over the last 6 months – not to mention a rise of 167.25% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHVN stock in for the last two-week period is set at 74.33, with the RSI for the last a single of trading hit 83.85, and the three-weeks RSI is set at 67.89 for Biohaven Ltd [BHVN]. The present Moving Average for the last 50 days of trading for this stock 38.48, while it was recorded at 41.03 for the last single week of trading, and 42.02 for the last 200 days.
Biohaven Ltd [BHVN]: Deeper insight into the fundamentals
Biohaven Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.27 and a Current Ratio set at 3.27.
Insider trade positions for Biohaven Ltd [BHVN]
There are presently around $89.30%, or 101.48%% of BHVN stock, in the hands of institutional investors. The top three institutional holders of BHVN stocks are: VANGUARD GROUP INC with ownership of 7.27 million shares, which is approximately 8.9114%. STIFEL FINANCIAL CORP, holding 6.48 million shares of the stock with an approximate value of $$224.94 million in BHVN stocks shares; and STIFEL FINANCIAL CORP, currently with $$214.15 million in BHVN stock with ownership which is approximately 7.5608%.
